Product Description
Overall, the global urinary catheter market was valued at $3.1 billion in 2021. This is expected to increase over the forecast period at a CAGR of 2.5% to reach $3.7 billion. On the other hand, the global urinary guidewire market was valued at $208 million in 2021. This is expected to increase over the forecast period at a CAGR of 1.8% to reach nearly $237 million.
The full report suite on the global market for urinary guidewires includes all guidewires to be used in urological procedures including nitinol and stainless-steel guidewires, as well as polytetrafluoroethylene (PTFE) coated guidewires. The full report suite on the global market for urinary catheters includes intermittent, Foley and male external catheter segments.
MARKET REPORT DATA TYPES INCLUDED
- Unit Sales, Procedure Numbers, Average Selling Prices, Market Value & Growth Trends
- 10 Year Scope
- Market Drivers & Limiters for Each Segment
- Competitive Analysis with Market Shares for Each Segment
- Recent Mergers & Acquisitions
- Disease Overviews and Demographic Information
- Company Profiles, Product Portfolios and SWOT for Top Competitors
GLOBAL URINARY CATHETER MARKET TRENDS
The commoditization of catheter products will continue to limit growth in the total market. Catheters are becoming more homogeneous, commoditized products. This limits the ability of manufacturers to increase catheter prices. However, a continued shift to in-home catheterization will drive growth in the intermittent catheter market.
GLOBAL URINARY GUIDEWIRE MARKET TRENDS
Guidewires are used in many endoscopic procedures to aid a physician in placing their instrument in the correct location for a procedure. The urinary guidewire market is projected to grow over the forecast period, driven by the increasing popularity of minimally invasive procedures and procedures which have been adapted to be performed endoscopically.
GLOBAL URINARY CATHETER MARKET SHARE INSIGHTS
Overall, within the global urinary catheter market there are three dominant competitors: Coloplast, Becton Dickinson, and Wellspect Healthcare.
In 2021, the market leader in urinary catheters was Coloplast. The company offers the Self-Cath® and SpeediCath® intermittent catheters, as well as the Conveen® MEC. Coloplast’s market share is expected to continue to increase, due to the growth expected in the intermittent catheter market.
GLOBAL URINARY GUIDEWIRE MARKET SHARE INSIGHTS
Overall, within the global urinary Guidewire market there are three dominant competitors: Coloplast, Cook Medical, and Boston Scientific.
In 2021, the market leader in urinary guidewires was Coloplast. The company manufactures a number of product types including both stainless-steel and nitinol devices, as well as coated devices.
GLOBAL URINARY CATHETER MARKET SEGMENTATION SUMMARY
- Global Intermittent Catheter Market
- Global Foley Catheter
- Global Male External Catheter
GLOBAL URINARY GUIDEWIRE MARKET SEGMENTATION SUMMARY
- Global Nitinol Guidewire Market
- Global Stainless-steel Guidewire Market
- Global Polytetrafluoroethylene (PTFE) Coated Guidewire Market
GLOBAL RESEARCH SCOPE
Report Attribute | Details |
---|---|
Regions | North America (Canada, United States) Latin America (Argentina, Brazil, Chile, Colombia, Mexico, Peru, Venezuela) Western Europe (Austria, Benelux, France, Germany, Italy, Portugal, Scandinavia, Spain, Switzerland, U.K.) Central & Eastern Europe (Baltic States, Bulgaria, Croatia, Czech Republic, Greece, Hungary, Kazakhstan, Poland, Romania, Russia, Turkey, Ukraine) Middle East (Bahrain, Iran, Israel, Kuwait, Oman, Qatar, Saudi Arabia, United Arab Emirates) Asia Pacific (Australia, Cambodia, China, Hong Kong, India, Indonesia, Japan, Malaysia, Myanmar, New Zealand, Philippines, Singapore, South Korea, Taiwan, Thailand, Vietnam) Africa (Algeria, Egypt, Ghana, Kenya, Libya, Morocco, Nigeria, South Africa, Sudan, Uganda) |
Base Year | 2021 |
Forecast | 2022-2028 |
Historical Data | 2018-2021 |
Quantitative Coverage | Market Size, Market Shares, Market Forecasts, Market Growth Rates, Units Sold, and Average Selling Prices. |
Qualitative Coverage | COVID19 Impact, Market Growth Trends, Market Limiters, Competitive Analysis & SWOT for Top Competitors, Mergers & Acquisitions, Company Profiles, Product Portfolios, FDA Recalls, Disruptive Technologies, Disease Overviews. |
Data Sources | Primary Interviews with Industry Leaders, Government Physician Data, Regulatory Data, Hospital Private Data, Import & Export Data, iData Research Internal Database. |
WHY CHOOSE iDATA?
- Experts Only – iData has been around for over 17 years and is the trusted source of intelligence, and data-driven insights for key industry players. We are made up of specialists with a sole focus on medical devices, dental devices and pharmaceuticals. Our research and consulting field of endeavour never strays from the medical device industry and, because of this, we are the number one choice for leading companies in this field.
- Global Coverage – iData’s unique methodology, and its expansion to over 70 countries world-wide, has made it one of the most viable sources of intelligence for global companies along with those who plan to expand their portfolio beyond the confines of their own country. Providing procedural data at the country level is another testimony to the trusted global coverage we provide.
- Attention to Detail – It’s our attention to small details, scheduling of timelines, and keen project management that makes us stand out from the rest. We are creative, and our reports include metrics such as procedure numbers, ASPs, and SKU-level insights that are not found elsewhere.
- Pricing – When comparing like-with-like, iData’s prices are not only extremely competitive but also the most cost-effective. We strive for success and want the same for our clients. With the level of detail incorporated into each report alongside the extensive segmentation provided, no other report compares at our price point.
This MedCore is also found in the full report suite titled Urology Market which contains several other extremities medical device markets.